phrykt

Satellos Bioscience Inc. (MSLE): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of MSLE were reported in the last 12 months. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Satellos Bioscience

From the latest filings

Overall: about as much buying as selling. Funds mostly sold. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MSLE

26 funds and institutions reported MSLE shares worth $59.6M at the end of Q2 2026, about 50% of the company. The largest holder is Franklin Resources Inc with 6.1%.

Funds and institutions (13F) 50%Everyone else 50%

10 largest owners, by share of the company

Franklin Resources Inc6.1%
Siren, L.L.C.5.8%
Vivo Capital, LLC5.3%
Point72 Asset Management, L.P.4.4%
Sphera Funds Management Ltd.4.2%
Woodline Partners LP3.2%
Stonepine Capital Management, LLC3.2%
Montanova Capital, LLC3.1%
Avidity Partners Management LP2.5%
Saturn V Capital Management LP2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Franklin Resources Inc938,6666.07%$7.2MNo change
Siren, L.L.C.892,0745.77%$6.9MNo change
Vivo Capital, LLC813,6665.26%$6.3MNo change
Point72 Asset Management, L.P.682,7004.42%$5.3M-1%
Sphera Funds Management Ltd.652,5904.22%$5.1M+33%
Woodline Partners LP500,4323.24%$3.9MNo change
Stonepine Capital Management, LLC491,6243.18%$3.7M+392%
Montanova Capital, LLC475,0003.07%$3.7MNo change
Avidity Partners Management LP387,7692.51%$3M-50%
Saturn V Capital Management LP350,0002.26%$2.7MNo change
Soleus Capital Management, L.P.314,3592.03%$2.4M-24%
683 Capital Management, LLC230,8331.49%$1.8MNo change
ADAR1 Capital Management, LLC222,5551.44%$1.7MNo change
AWM Investment Company, Inc.180,0001.16%$1.4MNew
Millennium Management LLC152,7680.99%$1.2M-49%
Adage Capital Partners Gp, L.l.c.150,0000.97%$1.2M-61%
Empery Asset Management, LP107,1000.69%$833K-53%
Citadel Advisors LLC67,7380.44%$527K+59%
Morgan Stanley25,7320.17%$200K+21%
China Universal Asset Management Co., Ltd.20,0000.13%$156K+212%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No MSLE insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MSLE short interest

127,108 MSLE shares are sold short. Over the last 12 reports the number of shares short went up 50%.

As of Oct 30, 2026, 127,108 MSLE shares were sold short, up 30.7% from the report before. At the average daily volume of 32,942 shares, buying them all back would take about 3.9 trading days (days to cover).

Shares short, % of all shares

0.67%May 15Jul 150.71%

Days to cover

3.9May 15Oct 304.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026127,108–+31%32,9423.9
Oct 15, 202697,288–-8%61,0771.6
Sep 30, 2026105,687–+28%66,7351.6
Sep 15, 202682,427–-7%31,9452.6
Aug 31, 202689,063–-3%20,8304.3
Aug 14, 202691,665–-19%27,1343.4
Jul 31, 2026113,110–+9%66,8141.7
Jul 15, 2026104,0970.67%+25%123,1551.0
Jun 30, 202683,4880.54%+19%48,1001.7
Jun 15, 202670,1880.45%-9%36,5421.9
May 29, 202676,8180.50%-9%25,6053.0
May 15, 202684,8550.55%-11%33,3802.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold MSLE

3 of the 50 well-known investors we track reported holding MSLE in their latest 13F filing. The largest position is Steve Cohen's, worth $5.8M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 2026681,800$5.8M0.0%-0%
Israel Englander · Millennium ManagementQ3 2026253,796$2.2M0.0%+66%
Ken Griffin · Citadel AdvisorsQ3 202643,190$367K0.0%-36%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Satellos Bioscience Inc. (MSLE) stock

Who owns the most MSLE stock?

The largest reported owner of Satellos Bioscience Inc. (MSLE) is Franklin Resources Inc, with 6.1% of the company. In total, 26 funds and institutions reported holding MSLE at the end of Q2 2026, together about 50% of the shares. See the largest owners.

Are MSLE insiders buying or selling?

No MSLE insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in MSLE?

As of Oct 30, 2026, 127,108 MSLE shares were sold short, up 30.7% from the report before. At the average daily volume of 32,942 shares, buying them all back would take about 3.9 trading days (days to cover). See the history.

Which famous investors hold MSLE?

3 of the 50 well-known investors we track reported MSLE in their latest 13F filing, including Steve Cohen, Israel Englander, Ken Griffin. The largest position is worth $5.8M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.